Proteomics Market Analysis By Product (Instruments, Reagents, Services), By Technology (Microarray, X-Ray Crystallography, Spectroscopy, Chromatography, Protein Fractionation Systems, Electrophoresis, Surface Plasma Resonance Systems), By Application (Drug Discovery, Clinical Diagnosis), And Segment Forecasts To 2024

1. FollowUs:
Proteomics Market Future Growth , Industry Size ,Share ,Revenue And
Forecast To 2024| Grand View Research, Inc
The global proteomics market is expectedto reach over USD 24.8 billionby 2024 according to a new report by
Grand ViewResearch, Inc. The introduction of technology-enabledproteomicsproducts is one of the high-impact
rendering driversfor the proteomics market growth. These products findextensive applicationsin drug discovery,
diagnostic services, and many other research areas. The increasing market penetrationof these technologies,such
as ESI-LC-MS (electrospray ionizationliquidchromatography mass spectrometry), is expectedto serve as a driver of
this market.
Proteomics has become a powerful tool for treating various diseasessuch as diabetes,fatty liver,obesity,and deadly
cancers. It is difficultto cure these diseasesas body responses vary from person to person; to overcome this
problem,researcher from Ecole Polytechnique Fédérale de Lausanne and ETH Zurich in Switzerlanddeveloped
method to define metabolic differencesbetweenindividuals.Thisisexpectedto drive the demandfor proteomics
over the forecast period.
The presence of organizations such as the Human Proteome Organization promotes the developmentof new
techniques,technologies,and training pertainingto the fieldof proteomics. This is expectedto propel the market
growth over the forecast period.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/proteomics-market
“The global proteomicsmarket was valued at over USD 11.8 billion in 2015..”

2. FollowUs:
Further Key Findings From the Study Suggest:
 The reagents segment dominatedthe product segmentin 2015 and is expectedto witnessa lucrative growth
with a CAGR of over 8.5%. Extensive usage of reagents for R&D activitiesand the introduction of novel
biomarker-specifickits, such as Pro2PSA biomarker for prostate cancer and CA27.29biomarkers for breast
cancer, are the factors responsible for its large market share.
 The instruments segmentis anticipated to show a significantgrowth over the forecast period.The major
factor responsible for the growth is the rising demand for user-friendly,cost-effective,rapid,and accurate
devices
 In 2014, the protein microarray segmentoccupied over45% of the market share of the proteomics market,
owing to the high usage rates of this technology. Microarray technology has the abilityto track the protein
interactions and performs chromatography and 2-Delectrophoresisin a comparatively lessertime.
 The spectroscopy segmentis one of the fastest growing segmentsof proteomics market. The introduction of
novel technologiessuch as Orbitrap Mass spectroscopy and the increasing demand for rapid and accurate
devicesfor complete analysis of proteins are the factors responsible for its fastest growth.
 North America heldthe largest share of over 40% in 2015. The presence of favorable government initiatives
and the growing adoption of personalizedmedicinesare the key factors that can be attributed to the major
revenue share in the market.
 Asia Pacific is expectedto be the fastest growing with a share of over 12% in 2015.The growing prevalence of
chronic diseasesin the developingcountriesis a key factor responsible for the fastest growth in Asia Pacific.
Grand ViewResearch has segmentedthe proteomics market on the basis of product, technology, application, and
region:
Proteomics Market Product Outlook, by Revenue (USD Million, 2013 & 2024)
 Instruments
 Reagents
 Services
Proteomics Market Technology Outlook, by Revenue (USD Million, 2013 & 2024)
 Microarray Instruments
 X-Ray Crystallography
 Spectroscopy
 Chromatography
 Protein Fractionation Systems
 Electrophoresis
 Surface Plasma Resonance Systems
Proteomics Market Application Outlook, by Revenue (USD Million, 2013 & 2024)
 Drug Discovery
 Clinical Diagnosis

3. FollowUs:
 Others
Proteomics Market Regional Outlook, by Revenue (USD Million, 2015 & 2024)
 North America
o U.S.
o Canada
 Europe
o Germany
o UK
 Asia Pacific
o Japan
o China
 Latin America
o Brazil
 MEA
o SouthAfrica
Browse Related Category Reports @ www.grandviewresearch.com/industry/biotechnology
Table of Content of Proteomics Market
Chapter 1. Methodologyand Scope
1.1. Research Methodology
1.2. ResearchScope & Assumptions
1.3. Listof Data Sources
Chapter 2. Executive Summary
2.1. ProteomicsMarket - IndustrySnapshotandKeyBuyingCriteria,2015
Chapter 3. Proteomics Industry Outlook
3.1. ProteomicsMarketSegmentation
3.2. ProteomicsMarketSize andGrowthProspects
3.3. ProteomicsMarketDynamics
3.3.1. Market driveranalysis
3.3.1.1. Rise ingeriatricpopulationdemandingpersonalizedmedicines
3.3.1.2. Growingdemandforadvanceddiagnosticsintargeteddisease treatment
3.3.1.3. Growingprevalence of targetdiseases

4. FollowUs:
3.3.1.4. Otherdrivers
3.3.2. Market restraintanalysis
3.3.2.1. Presence of ambiguousregulatoryframework
3.3.2.2. High procedure costs
3.4. KeyOpportunitiesPrioritized
3.5. IndustryAnalysis - Porter's
3.6. ProteomicMarketPESTEL Analysis,2015
3.7. Proteomicscompanymarketshare analysis,2015
Chapter 4. Proteomics Product Outlook
4.1. ProteomicsMarketShare byProduct,2015 & 2024
4.2. Instruments
4.2.1. Instrumentsmarketestimates,2013 - 2015 (USD Million)
4.2.2. Instrumentsmarketforecasts,2016 - 2024 (USD Million)
4.3. Reagents
4.3.1. Reagentsmarketestimates,2013 - 2015 (USD Million)
4.3.2. Reagentsmarketforecasts,2016 - 2024 (USD Million)
4.4. Services
4.4.1. Servicesmarketestimates,2013 - 2015 (USD Million)
4.4.2. Servicesmarketforecasts,2016 - 2024 (USD Million)
Chapter 5. Proteomics ApplicationOutlook
5.1. ProteomicsMarketShare byApplication,2015 & 2024
5.2. Drug Discovery
5.2.1. Drug discoverymarketestimates,2013 - 2015 (USD Million)
5.2.2. Drug discoverymarketforecasts,2016 - 2024 (USD Million)
5.3. Clinical Diagnosis
5.3.1. Clinical diagnosismedicinemarketestimates,2013 - 2015 (USD Million)
5.3.2. Clinical diagnosismedicinemarketforecasts, 2016 - 2024 (USD Million)
5.4. Others
5.4.1. Othersmarketestimates,2015 - 2024 (USD Million)
5.4.2. Othersmarketforecasts,2016 - 2024 (USD Million)
Chapter 6. Proteomics TechnologyOutlook
6.1. ProteomicsMarketShare byTechnology,2015 & 2024

5. FollowUs:
6.2. Microarray Instruments
6.2.1. Microarray instrumentsmarketestimates,2013 - 2015 (USDMillion)
6.2.2. Microarray instrumentsmarketforecasts,2016 - 2024 (USD Million)
6.3. X-RayCrystallography
6.3.1. X-Raycrystallographymarketestimates,2013 - 2015 (USD Million)
6.3.2. X-Raycrystallographymarketforecasts,2016 - 2024 (USD Million)
6.4. Spectroscopy
6.4.1. Spectroscopymarketestimates,2013 - 2015 (USD Million)
6.4.2. Spectroscopymarketforecasts,2016 - 2024 (USD Million)
6.5. Chromatography
6.5.1. Chromatographymarketestimates,2013 - 2015 (USD Million)
6.5.2. Chromatographymarketforecasts,2016 - 2024 (USDMillion)
6.6. Protein FractionationSystems
6.6.1. Proteinfractionationsystemsmarketestimates,2013 - 2015 (USD Million)
6.6.2. Proteinfractionationsystemsmarketforecasts,2016 - 2024 (USD Million)
6.7. Electrophoresis
6.7.1. Electrophoresismarketestimates,2013 - 2015 (USD Million)
6.7.2. Electrophoresisforecasts,2016 - 2024 (USD Million)
6.8. Surface PlasmaResonance (SPR) Systems
6.8.1. SPR systemsmarketestimates,2013 - 2015 (USD Million)
6.8.2. SPR systemsmarketforecasts,2016 - 2024 (USD Million)
Chapter 7. Proteomics Regional Outlook
7.1. ProteomicsMarketShare byRegion,2015 & 2024
7.2. NorthAmerica
7.2.1. NorthAmericamarketestimates,byproduct,2013 - 2015 (USD Million)
7.2.2. NorthAmericamarketforecasts,byproduct,2016 - 2024 (USD Million)
7.2.2.1. U.S.
7.2.2.2. Canada
7.2.3. NorthAmericamarketestimates,byapplication,2013 - 2015 (USD Million)
7.2.4. NorthAmericamarketforecasts,byapplication,2016 - 2024 (USD Million)
7.2.4.1. U.S.
7.2.4.2. Canada

6. FollowUs:
7.2.5. NorthAmericamarketestimates,bytechnology,2013 - 2015 (USD Million)
7.2.6. NorthAmericamarketforecasts,bytechnology,2016 - 2024 (USD Million)
7.2.6.1. U.S.
7.2.6.2. Canada
7.3. Europe
7.3.1. Europe marketestimates,byproduct,2013 - 2015 (USD Million)
7.3.2. Europe marketforecasts,byproduct,2016 - 2024 (USD Million)
7.3.2.1. Germany
7.3.2.2. UK
7.3.3. Europe marketestimates,byapplication,2013 - 2015 (USD Million)
7.3.4. Europe marketforecasts,byapplication,2016 - 2024 (USD Million)
7.3.4.1. Germany
7.3.4.2. UK
7.3.5. Europe marketestimates,bytechnology,2013 - 2015 (USD Million)
7.3.6. Europe marketforecasts,bytechnology,2016 - 2024 (USD Million)
7.3.6.1. Germany
7.3.6.2. UK
7.4. AsiaPacific
7.4.1. AsiaPacificmarketestimates,byproduct,2013 - 2015 (USD Million)
7.4.2. AsiaPacificmarketforecasts,byproduct,2016 - 2024 (USDMillion)
7.4.2.1. Japan
7.4.2.2. China
7.4.3. AsiaPacificmarketestimates,byapplication,2013 - 2015 (USD Million)
7.4.4. AsiaPacificmarketforecasts,byapplication,2016 - 2024 (USD Million)
7.4.4.1. Japan
7.4.4.2. China
7.4.5. AsiaPacificmarketestimates,bytechnology,2013 - 2015 (USD Million)
7.4.6. AsiaPacificmarketforecasts,bytechnology,2016 - 2024 (USD Million)
7.4.6.1. Japan
7.4.6.2. China
7.5. LatinAmerica
7.5.1. Latin Americamarket estimates,byproduct,2013 - 2015 (USD Million)

7. FollowUs:
7.5.2. Latin Americamarketforecasts,byproduct,2016 - 2024 (USD Million)
7.5.2.1. Brazil
7.5.3. Latin Americamarketestimates, byapplication,2013 - 2015 (USD Million)
7.5.4. Latin Americamarketforecasts,byapplication,2016 - 2024 (USD Million)
7.5.4.1. Brazil
7.5.5. Latin Americamarketestimates,by technology,2013 - 2015 (USD Million)
7.5.6. Latin Americamarketforecasts,bytechnology,2016 - 2024 (USD Million)
7.5.6.1. Brazil
7.6. MEA
7.6.1. MEA marketestimates,byproduct,2013 - 2015 (USD Million)
7.6.2. MEA marketforecasts,byproduct,2016 - 2024 (USD Million)
7.6.2.1. SouthAfrica
7.6.3. MEA marketestimates,byapplication,2013 - 2015 (USD Million)
7.6.4. MEA marketforecasts,byapplication,2016 - 2024 (USD Million)
7.6.4.1. SouthAfrica
7.6.5. MEA marketestimates,bytechnology,2013 - 2015 (USD Million)
7.6.6. MEA marketforecasts,bytechnology,2016 - 2024 (USD Million)
7.6.6.1. SouthAfrica
Chapter 8. Competitive Landscape
8.1. Illumina,Inc.
8.1.1. CompanyOverview
8.1.2. Financial Performance
8.1.3. ProductBenchmarking
8.1.4. StrategicInitiatives
8.2. AgilentTechnologies,Inc.
8.2.1. CompanyOverview
8.2.2. Financial Performance
8.2.3. ProductBenchmarking
8.2.4. StrategicInitiatives
8.3. Bio- Rad Laboratories,Inc.
8.3.1. CompanyOverview
8.3.2. Financial Performance

8. FollowUs:
8.3.3. ProductBenchmarking
8.3.4. StrategicInitiatives
8.4. GE Healthcare
8.4.1. CompanyOverview
8.4.2. Financial Performance
8.4.3. ProductBenchmarking
8.4.4. StrategicInitiatives
8.5. ThermoFisherScientific,Inc.
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. ProductBenchmarking
8.5.4. StrategicInitiatives
8.6. Sigma- Aldrich
8.6.1. CompanyOverview
8.6.2. Financial Performance
8.6.3. ProductBenchmarking
8.6.4. StrategicInitiatives
8.7. Roche Diagnostics
8.7.1. CompanyOverview
8.7.2. Financial Performance
8.7.3. ProductBenchmarking
8.7.4. StrategicInitiative

9. FollowUs:
About Us:
Grand ViewResearch, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To helpclients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist,USA
Grand ViewResearch, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com

10. FollowUs: